Jump to navigation
The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
A US trial among 15 to 17 year-old men who have sex with men (MSM) suggests this group stands to benefit hugely should pre-exposure prophylaxis (PrEP) be approved – and supported – for this age group.
Learn the facts about COVID-19 and what it means for people living with HIV.